- Home
- LUCY vs CSCI Comparison
LUCY vs CSCI Comparison
Compare LUCY & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCY
- CSCI
- Stock Information
- Founded
- LUCY 2017
- CSCI 1990
- Country
- LUCY United States
- CSCI Canada
- Employees
- LUCY N/A
- CSCI N/A
- Industry
- LUCY Ophthalmic Goods
- CSCI
- Sector
- LUCY Health Care
- CSCI
- Exchange
- LUCY Nasdaq
- CSCI NYSE
- Market Cap
- LUCY 8.9M
- CSCI 10.5M
- IPO Year
- LUCY 2022
- CSCI 1996
- Fundamental
- Price
- LUCY $2.87
- CSCI $3.61
- Analyst Decision
- LUCY
- CSCI
- Analyst Count
- LUCY 0
- CSCI 0
- Target Price
- LUCY N/A
- CSCI N/A
- AVG Volume (30 Days)
- LUCY 2.5M
- CSCI 3.3K
- Earning Date
- LUCY 05-13-2025
- CSCI 05-13-2025
- Dividend Yield
- LUCY N/A
- CSCI N/A
- EPS Growth
- LUCY N/A
- CSCI N/A
- EPS
- LUCY N/A
- CSCI N/A
- Revenue
- LUCY $1,707,470.00
- CSCI $9,030,000.00
- Revenue This Year
- LUCY $367.48
- CSCI N/A
- Revenue Next Year
- LUCY $166.67
- CSCI N/A
- P/E Ratio
- LUCY N/A
- CSCI N/A
- Revenue Growth
- LUCY 22.75
- CSCI 36.51
- 52 Week Low
- LUCY $1.57
- CSCI $1.96
- 52 Week High
- LUCY $15.88
- CSCI $7.72
- Technical
- Relative Strength Index (RSI)
- LUCY 53.14
- CSCI N/A
- Support Level
- LUCY $2.61
- CSCI N/A
- Resistance Level
- LUCY $3.19
- CSCI N/A
- Average True Range (ATR)
- LUCY 0.33
- CSCI 0.00
- MACD
- LUCY -0.00
- CSCI 0.00
- Stochastic Oscillator
- LUCY 27.64
- CSCI 0.00
About LUCY Innovative Eyewear Inc.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok.
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.